An interventional study of Casein phosphopeptide-amorphous calcium phosphate and Casein phosphopeptide-amorphous calcium phosphate + fluoride in White Spot Lesion of Tooth, sponsored by National Research Centre, Egypt. Completed at 1 site in Egypt. Open to participants aged 10 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-12.
Sponsored by National Research Centre, Egypt · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
One hundred children with white spot lesions on their teeth were divivided into 5 groups of different remineralizing agents to assess their effect on color change and remineralization
Children having at least one tooth clinically diagnosed by white spot lesion were randomly allocated to five groups.
Group one: No treatment was applied (negative control). Group two: Fluoride gel was applied for 5 minutes (positive control). Group three: Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) (MI paste) was applied for 5 minutes.
Group four: Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) + fluoride (MI paste plus) were applied for 5 minutes.
Group five: Nano hydroxyapatite paste (Apagard primo toothpaste) was be applied for 5 minutes.
All children involved in this study were instructed to brush their teeth under the supervision of the researcher before the application of the studied agent.
Each agent was applied to the labial surfaces of each tooth affected with white spot lesion for 5 minutes after cleaning and drying with a cotton roll using an applicator tip. After each application, children were instructed not to eat or drink for one hour. This application was be repeated in-office after one then after two weeks then after six weeks.
Participants received a sterilized pouch containing a sterile container with one of the pastes according to the study group for home application. The application of the paste was carried out under parental supervision and was asked to apply each of the pastes at home three times a day till the end of the study
National Research Centre, Egypt is the lead sponsor of 51 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Negative control
Positive control
Drug: Fluoride gel
Intervention
Drug: Casein phosphopeptide-amorphous calcium phosphate
Intervention
Drug: Casein phosphopeptide-amorphous calcium phosphate + fluoride
Intervention
Drug: Nano hydroxyapatite paste
Intervention
Also known as: (CPP-ACP) (MI paste)
Intervention
Also known as: (CPP-ACP) + (MI paste plus)
Intervention
Also known as: (Apagard primo toothpaste)
Positive control
Also known as: Active Comparator
Assessment of color change
Color change assessmentof white spot lesions using "Easy-shade" device
Time frame: before treatment, immediately after treatment, 2 weeks and 6 weeks after the onset of treatment
Remineralization assessment
Remineralization assessment will be done using Laser fluorescence device "DIAGNOdent® (KaVo)".
Time frame: before treatment, immediately after treatment, 2 weeks and 6 weeks after the onset of treatment
Ran from Dec 2024 to primary completion in Jan 2025, 1 month.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Research Centre, Egypt